<DOC>
	<DOCNO>NCT01278953</DOCNO>
	<brief_summary>The TOCCASTAR Study assess safety effectiveness contact force sense catheter use ablation patient paroxysmal atrial fibrillation . Subjects randomized treatment either TactiCath catheter another ablation catheter contact force sense capability . Patients follow 12 month compare incidence serious adverse event freedom recur , symptomatic AF two study arm . Additional measure treatment success include quality life , recurrence asymptomatic AF procedural efficiency also study . A second phase study treat 50 non-randomized subject new version device protocol .</brief_summary>
	<brief_title>TOCCASTAR - TactiCath Contact Force Ablation Catheter Study Atrial Fibrillation</brief_title>
	<detailed_description>It hypothesize ability create durable lesion radiofrequency ( RF ) ablation directly correlate reduction recurrence arrhythmia patient paroxysmal atrial fibrillation ( PAF ) . Lesion depth directly correlate contact force measure tip catheter heart tissue . In study , patient pulmonary vein isolation procedure prescribe treatment PAF randomize treatment either device incorporate contact force sense one without . To include study , patient 18 old must demonstrate history atrial fibrillation fail treatment use antiarrhythmic medication . In study arm , ablation perform use accepted treatment strategy standard procedure . Patients receive routine follow-up 12 month procedure , addition ambulatory monitoring detect recurrence episode atrial arrhythmia . The study compare effectiveness procedure two arm , characterize difference safety outcome primarily relate complication arise use ablation device ablation procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>symptomatic PAF refractory least one Class IIV antiarrhythmic drug minimum one document PAF episode &gt; 30 sec duration within prior 12 month minimum three PAF episodes prior 12 month 18 year old persistent longstanding persistent AF four cardioversions prior 12 month MI , CABG PCI within precede 3 month leave atrial diameter &gt; 5.0 cm LVEF &lt; 35 % NYHA class III IV previous leave atrial ablation procedure previous tricuspid mitral valve repair surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>paroxysmal atrial fibrillation</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>radiofrequency ablation</keyword>
	<keyword>pulmonary vein isolation</keyword>
	<keyword>ablation catheter</keyword>
	<keyword>RF</keyword>
	<keyword>contact force sensing</keyword>
	<keyword>contact force</keyword>
	<keyword>contact force assist ablation</keyword>
</DOC>